Genentech will have access to Sangamo’s capsid delivery platform and epigenetic regulation capabilities to develop genomic medicines for certain neurodegenerative diseases.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Lonza and Oxford Nanopore Partner on mRNA Analytics

By Feliza Mirasol

February 2nd 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Exploring Best Practice Tech Transfer Methods for CGTs

By Matthew Hewitt
Larry Bellot

Chad Andersen

December 6th 2023

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.

<1 2 3

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777